Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Edwards Lifesciences (EW) Shares Issued (2016 - 2026)

Edwards Lifesciences has reported Shares Issued over the past 17 years, most recently at $32.3 million for Q4 2025.

For Q4 2025, Shares Issued rose 12.94% year-over-year to $32.3 million; the TTM value through Dec 2025 reached $174.1 million, down 3.01%, while the annual FY2025 figure was $174.1 million, 3.01% down from the prior year.
Shares Issued for Q4 2025 was $32.3 million at Edwards Lifesciences, down from $34.7 million in the prior quarter.
Over five years, Shares Issued peaked at $62.1 million in Q1 2024 and troughed at $27.5 million in Q4 2022.
A 5-year average of $41.4 million and a median of $36.1 million in 2022 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: surged 48.21% in 2024 and later fell 19.65% in 2025.
Year by year, Shares Issued stood at $33.9 million in 2021, then fell by 18.88% to $27.5 million in 2022, then increased by 20.73% to $33.2 million in 2023, then decreased by 13.86% to $28.6 million in 2024, then grew by 12.94% to $32.3 million in 2025.
Business Quant data shows Shares Issued for EW at $32.3 million in Q4 2025, $34.7 million in Q3 2025, and $57.2 million in Q2 2025.